Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047046 · ClinicalTrials.gov registry record
Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder
A clinical trial of Overactive Bladder, sponsored by University of California, Irvine.
- Completed
- Registry status
- 88
- Enrollment target
- 1
- Study location
NCT01047046: Completed study of Overactive Bladder, sponsored by University of California, Irvine.
NCT01047046 is a study of Overactive Bladder that has completed, run by University of California, Irvine. The registered enrollment target is 88 participants, below the 206-participant average among 46 other Overactive Bladder trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01047046, a study of Overactive Bladder, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a retrospective chart review including all patients who received surgical placement of a SNM device with Dr. Noblett from 2001 to the present.
Conditions Studied
Interventions
- OTHER Retrospective chart review
Study Locations (1)
California
- UCI Women's Healthcare - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-12 |
What the finished NCT01047046 record still lists
NCT01047046 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 206-participant average among 46 other Overactive Bladder trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which Retrospective chart review is the first listed.
NCT01047046 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01047046 about?
NCT01047046 is a clinical study titled "Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder". This study is a retrospective chart review including all patients who received surgical placement of a SNM device with Dr. Noblett from 2001 to the present.
What is the current status of trial NCT01047046?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2008-01. Estimated completion is 2009-12.
What conditions does trial NCT01047046 study?
This clinical trial studies the following conditions: Overactive Bladder.
What interventions are being tested in trial NCT01047046?
The interventions under investigation include: Retrospective chart review (OTHER).
Who is sponsoring clinical trial NCT01047046?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01047046 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01047046's enrollment target sits among peer trials
88 26th of 46 higher than 21 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
RECRUITING
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia